In response to Minaris\u2019 US factory closure, ACGO\u00ae production will be domestically integrated. Upstream processes will be transferred to the Yokohama Factory to establish a vertically integrated manufacturing system. We will advance dual-track production to enhance manufacturing stability and supply capacity. The impact on this fiscal year’s performance is unclear, but there is currently no material impact.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4592","jir_company_name":"SanBio Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4592-20260902-01.pdf","jir_short_summary":"In response to Minaris\u2019 US factory closure, ACGO\u00ae production will be domestically integrated. Upstream processes will be transferred to the Yokohama Factory to establish a vertically integrated manufacturing system. We will advance dual-track production to enhance manufacturing stability and supply capacity. The impact on this fiscal year's performance is unclear, but there is currently no material impact.","jir_summary":"### Overview of this matter\nSanBio plans to close Minaris' Mountain View factory responsible for ACGO\u00ae production and transfer upstream operations to the Yokohama factory in Japan, strengthening a domestically integrated system that handles both upstream and downstream processes. This aims to improve domestic manufacturing stability and supply capacity. Domestic inventories are already secured, so there will be no supply shortage during the transfer period. Additionally, a pilot manufacturing agreement with JCR Pharma has been concluded to pursue commercial manufacturing, promoting dual-track manufacturing.\n\n### Future impact and outlook\nThrough domestic integration and dual-track manufacturing, we are building a production framework to prepare for future US expansion and potential expansion of indications for stroke. At present, the company states there is no material impact on this fiscal year's performance, and any new disclosures will be made promptly as they arise.","jir_financial_highlights":"Impact on this term's performance: Unknown (Unknown)","jir_category":"","jir_hashtags":"#SanBio, #ACGO, #ManufacturingIntegration, #SupplyStability","jir_key_figures":"Domestic integration of ACGO\u00ae manufacturing: Mountain View factory closure, transfer of upstream processes to Yokohama factory\nPilot manufacturing agreement with JCR Pharma Co., Ltd. (aiming for commercial manufacturing)\nEnsured supply stability through secured inventories (details not disclosed)","jir_meta_title":"SanBio Announces ACGO Domestic Integration Following Minaris Plant Closure | Prospects for Supply Stability","jir_meta_description":"SanBio, due to Minaris\u2019 US plant closure, is domestically integrating ACGO manufacturing. Upstream processes moved to the Yokohama factory to establish an integrated system. Dual-track manufacturing and strengthened stable supply are pursued, with no clear impact on this quarter's performance at this time. Details follow.","jir_og_title":"SanBio Announces ACGO Domestic Integration | Strengthening Supply Stability","jir_og_description":"Domestic integration due to Minaris' US plant closure, transferring upstream processes to Yokohama factory. Advancing dual-track manufacturing to ensure stable supply. Impact on this quarter's performance is currently unknown.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9416,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-110186","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n